Gemcitabine plus Nivolumab with Carboplatin or Oxaliplatin in Cisplatin-Ineligible Patients with Metastatic Urothelial Carcinoma: A Randomized Phase II Trial

Ziao Li, Sudeh Izadmehr, Jeannie Hoffman-Censits, Benjamin Maughan, Tina Mayer, Alan Tan, Rachel Brody, Hui Xie, Kai Nie, Geoffrey Kelly, Giorgio Ioannou, Rafael Cabal, Kevin Tuballes, Ruiwei Guo, Igor Figueiredo, Diane M. Del Valle, Reza Mehrazin, Menggang Yu, Qianqian Zhao, Seunghee Kim-Schulze, John P. Sfakianos, Santosh Gupta, Noah M. Hahn, Edgar Gonzalez-Kozlova, Sacha Gnjatic, Matthew D. Galsky

Open source

DOI: 10.1158/1078-0432.ccr-26-0469
Published: 2026-04-16
Container: Clinical Cancer Research
Publisher: American Association for Cancer Research (AACR)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-26-0469,
  title = {Gemcitabine plus Nivolumab with Carboplatin or Oxaliplatin in Cisplatin-Ineligible Patients with Metastatic Urothelial Carcinoma: A Randomized Phase II Trial},
  author = {Ziao Li and Sudeh Izadmehr and Jeannie Hoffman-Censits and Benjamin Maughan and Tina Mayer and Alan Tan and Rachel Brody and Hui Xie and Kai Nie and Geoffrey Kelly and Giorgio Ioannou and Rafael Cabal and Kevin Tuballes and Ruiwei Guo and Igor Figueiredo and Diane M. Del Valle and Reza Mehrazin and Menggang Yu and Qianqian Zhao and Seunghee Kim-Schulze and John P. Sfakianos and Santosh Gupta and Noah M. Hahn and Edgar Gonzalez-Kozlova and Sacha Gnjatic and Matthew D. Galsky},
  year = {2026},
  journal = {Clinical Cancer Research},
  doi = {10.1158/1078-0432.ccr-26-0469},
  url = {https://doi.org/10.1158/1078-0432.ccr-26-0469}
}

RIS

TY  - JOUR
TI  - Gemcitabine plus Nivolumab with Carboplatin or Oxaliplatin in Cisplatin-Ineligible Patients with Metastatic Urothelial Carcinoma: A Randomized Phase II Trial
AU  - Ziao Li
AU  - Sudeh Izadmehr
AU  - Jeannie Hoffman-Censits
AU  - Benjamin Maughan
AU  - Tina Mayer
AU  - Alan Tan
AU  - Rachel Brody
AU  - Hui Xie
AU  - Kai Nie
AU  - Geoffrey Kelly
AU  - Giorgio Ioannou
AU  - Rafael Cabal
AU  - Kevin Tuballes
AU  - Ruiwei Guo
AU  - Igor Figueiredo
AU  - Diane M. Del Valle
AU  - Reza Mehrazin
AU  - Menggang Yu
AU  - Qianqian Zhao
AU  - Seunghee Kim-Schulze
AU  - John P. Sfakianos
AU  - Santosh Gupta
AU  - Noah M. Hahn
AU  - Edgar Gonzalez-Kozlova
AU  - Sacha Gnjatic
AU  - Matthew D. Galsky
PY  - 2026
JO  - Clinical Cancer Research
DO  - 10.1158/1078-0432.ccr-26-0469
UR  - https://doi.org/10.1158/1078-0432.ccr-26-0469
ER  -

APA

Li, Z., Izadmehr, S., Hoffman-Censits, J., Maughan, B., Mayer, T., Tan, A., Brody, R., Xie, H., Nie, K., Kelly, G., Ioannou, G., Cabal, R., Tuballes, K., Guo, R., Figueiredo, I., Valle, D. M. D., Mehrazin, R., Yu, M., Zhao, Q., Kim-Schulze, S., Sfakianos, J. P., Gupta, S., Hahn, N. M., Gonzalez-Kozlova, E., Gnjatic, S., & Galsky, M. D. (2026). Gemcitabine plus Nivolumab with Carboplatin or Oxaliplatin in Cisplatin-Ineligible Patients with Metastatic Urothelial Carcinoma: A Randomized Phase II Trial. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-26-0469

Source records

crossref · retrieved 2026-09-26T21:25:13.860Z